The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Point-of-Care (POC) Coagulation Testing Global Market Report 2024, the point-of-care (POC) coagulation testing market is expected to show significant growth in the forecast period.

Strong Market Growth in Recent Years

• The point-of-care (POC) coagulation testing market has experienced significant growth.
• Market size grew from $1.12 billion in 2023 to $1.18 billion in 2024, with a CAGR of 5.9%.
• Growth drivers include:
  • Increased patient demand
  • Trend towards point-of-care testing
  • High reliability of coagulation tests
  • Integration with electronic health records (EHRs)
  • Rising incidence of cardiovascular diseases and blood disorders

Steady Growth Projected for the Future

• Market expected to grow to $1.42 billion by 2028, at a CAGR of 4.6%.
• Factors contributing to future growth:
  • Expanding healthcare applications
  • Rising demand in homecare settings
  • Increased prevalence of chronic blood disorders
  • Demand for rapid and accurate testing
  • Continued rise in point-of-care testing

View More On The Point-of-Care (POC) Coagulation Testing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report

Technological Advancements and Trends

• Major trends anticipated in the forecast period:
  • Technological advancements in testing
  • High demand in developed countries
  • Expanding applications in healthcare
  • Impact of COVID-19
  • Development of multiplexing POC diagnostics

Cardiovascular Disease Rates Fuel Market Expansion

• Rising cardiovascular disease rates are a significant growth driver.
• Cardiovascular diseases include coronary heart disease, cerebrovascular disease, and peripheral arterial disease.
• POC coagulation testing offers real-time coagulation status, crucial for treating cardiovascular diseases.
  • Enables timely decisions on coagulation interventions
  • Reduces risk of bleeding complications post-surgery
• For example, heart disease caused 695,000 deaths in the U.S. in 2021, according to the CDC.

Leading Companies in the POC Coagulation Testing Market

• Major players include:
  • AT&T Corporation
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Medtronic Plc
  • Koninklijke Philips N.V.
  • Sysmex Corporation
  • IDEXX Laboratories Inc.

Focus on Innovation and Collaboration

• Companies are focusing on strategic collaborations to enhance market position.
• Example: In October 2021, Trivitron Healthcare collaborated with Diagon Ltd. and Vanguard Diagnostics to launch Coagulation Analyzer products.
  • Aims to improve patient diagnosis and management
  • Diverse analyzers cater to various healthcare settings

Roche’s Strategic Acquisition

• In December 2023, Roche acquired LumiraDx Ltd. for $350 million.
  • Expands Roche’s diagnostic portfolio
  • Enhances patient-centric healthcare with comprehensive point-of-care solutions
• LumiraDx Ltd. specializes in POC coagulation testing

Market Segmentation and Regional Insights

• Market segmentation by technology:
  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology
• Distribution channels:
  • Direct Tenders
  • Retail
• End-users:
  • Hospitals
  • Clinics
  • Home care
• North America was the largest region in the POC coagulation testing market in 2023.

The point-of-care (POC) coagulation testing market is poised for continued growth, driven by technological advancements, increasing prevalence of cardiovascular diseases, and strategic collaborations among key players.

Request A Sample Of The Global Point-of-Care (POC) Coagulation Testing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=13913&type=smp